4DMedical Limited (ASX:4DX)
Australia · Delayed Price · Currency is AUD 3.640
0.00 (0.00%)
Aug 28, 2026, 4:10 PM AEST
4DMedical Financials Overview
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Revenue Revenue Growth | 7.06 | 7.06 | 5.85 | 3.75 | 0.72 | 1.05 |
Revenue Growth | 21.53% | 20.64% | 55.91% | 422.45% | -31.84% | 385.90% |
Gross Profit Gross Profit Growth | 6.62 | 6.62 | 5.39 | 3.52 | 0.68 | 0.28 |
Operating Income Operating Income Growth | -57.51 | -57.51 | -47.5 | -45.03 | -44.57 | -36.75 |
Net Income Net Income Growth | -204.44 | -204.44 | -30.07 | -35.98 | -31.46 | -24.59 |
Earnings Per Share EPS Growth | -0.03 | -0.03 | -0.14 | -0.11 | -0.10 | -0.08 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
United States of America United States of America Growth | 5.61 | 5.73 | 2.93 | 0.18 | 0.95 | 0.12 |
Australia Australia Growth | 0.21 | 0.12 | 0.82 | 0.54 | 0.1 | 0.1 |
Total Total Growth | 5.81 | 5.85 | 3.75 | 0.72 | 1.05 | 0.22 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash & Investments Cash & Investments Growth | 277.95 | 277.95 | 6.88 | 30.61 | 69.58 | 51.11 |
Total Debt Total Debt Growth | 11.17 | 11.17 | 4.31 | 5.12 | 5.14 | 6.24 |
Net Cash (Debt) Net Cash Growth | 266.79 | 266.79 | 2.57 | 25.49 | 64.44 | 44.88 |
Net Cash Growth | 473.51% | 10278.06% | -89.91% | -60.45% | 43.59% | -43.33% |
Net Cash Per Share Net Cash Per Share Growth | 0.04 | 0.04 | 0.01 | 0.07 | 0.21 | 0.14 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Operating Cash Flow Operating Cash Flow Growth | -31.27 | -31.27 | -34.48 | -30.87 | -22.65 | -25.27 |
Capital Expenditures CapEx Growth | -0.95 | -0.95 | -0.09 | -0.16 | -0.42 | -2.65 |
Free Cash Flow Free Cash Flow Growth | -32.22 | -32.22 | -34.56 | -31.02 | -23.07 | -27.92 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Gross Margin | 93.77% | 93.77% | 92.07% | 93.69% | 95.25% | 26.62% |
Operating Margin | -814.47% | -814.47% | -811.49% | -1199.53% | -6202.49% | -3485.78% |
Pretax Margin | -2911.11% | -2911.11% | -515.20% | -957.05% | -4333.06% | -2328.53% |
Profit Margin | -2895.06% | -2895.06% | -513.72% | -958.34% | -4378.05% | -2332.63% |
FCF Margin | -456.34% | -456.34% | -590.45% | -826.34% | -3211.05% | -2647.86% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 28, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
PS Ratio | 308.02 | 383.34 | 19.09 | 56.84 | 321.80 | 164.80 |